BR100 Decreased By (-0.81%)
BR30 Decreased By (-1.11%)
KSE100 Decreased By (-0.81%)
KSE30 Decreased By (-0.81%)
AGHA 7.59 Decreased By ▼ -0.10 (-1.3%)
BECO 5.51 Increased By ▲ 0.27 (5.15%)
BML 59.08 Decreased By ▼ -1.14 (-1.89%)
BOP 34.11 Decreased By ▼ -1.17 (-3.32%)
CNERGY 12.84 Decreased By ▼ -0.29 (-2.21%)
CSIL 6.10 Decreased By ▼ -0.01 (-0.16%)
FCCL 57.66 Decreased By ▼ -0.31 (-0.53%)
FFL 16.20 Decreased By ▼ -0.22 (-1.34%)
FNEL 1.21 Increased By ▲ 0.01 (0.83%)
KEL 7.48 No Change ▼ 0.00 (0%)
KOSM 5.94 Decreased By ▼ -0.10 (-1.66%)
LOTCHEM 27.99 Increased By ▲ 0.24 (0.86%)
MLCF 100.65 Decreased By ▼ -2.33 (-2.26%)
NBP 203.75 Decreased By ▼ -2.29 (-1.11%)
NCPL 60.57 Decreased By ▼ -1.67 (-2.68%)
NPL 69.96 Decreased By ▼ -1.33 (-1.87%)
OGDC 320.29 Decreased By ▼ -3.49 (-1.08%)
PACE 11.10 Decreased By ▼ -0.41 (-3.56%)
PAEL 43.12 Decreased By ▼ -0.78 (-1.78%)
PIBTL 16.56 Decreased By ▼ -0.12 (-0.72%)
PPL 228.84 Decreased By ▼ -0.63 (-0.27%)
PRL 71.02 Increased By ▲ 0.91 (1.3%)
PTC 71.65 Decreased By ▼ -0.50 (-0.69%)
SSGC 26.68 Decreased By ▼ -0.43 (-1.59%)
TBL 9.81 Decreased By ▼ -0.05 (-0.51%)
TELE 8.61 Decreased By ▼ -0.11 (-1.26%)
TPL 22.24 Decreased By ▼ -0.38 (-1.68%)
TPLP 15.11 Decreased By ▼ -0.57 (-3.64%)
TREET 24.13 Decreased By ▼ -0.08 (-0.33%)
TRG 59.84 Decreased By ▼ -1.29 (-2.11%)

KARACHI: Ali & Associates, in collaboration with the US Consulate General Karachi, successfully hosted a high-level roundtable on Biotechnology and Intellectual Property (IP) Law at its Karachi office. The event brought together leading representatives from government bodies, academia, pharmaceutical and biotech industries, and international organizations for a groundbreaking discussion on the future of biotechnology and intellectual property in Pakistan.

The roundtable explored the critical nexus between scientific research, healthcare innovation, and intellectual property frameworks, highlighting how stronger IP systems can accelerate biotech breakthroughs, foster research commercialization, and enhance access to advanced therapies for patients.

Prominent participants included representatives from the Intellectual Property Organization of Pakistan (IPO-Pakistan), the Drug Regulatory Authority of Pakistan (DRAP), the Pakistan Pharmaceutical Manufacturers Association (PPMA), leading academic and research institutions, as well as representatives from the pharmaceutical, biotechnology, and agricultural sectors.

Copyright Business Recorder, 2025

Comments

Comments are closed for this article.